Best Genomics Companies in Barcelona, Spain
The 31 best Genomics companies in Barcelona, Spain in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Splice Bio.
Our analysis of 50 Genomics companies
$7.8b in tracked funding; 84% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Genomics companies in Barcelona
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Splice Bio Provider of a proprietary platform for gene therapy 37Funding top 29%Growth top 45%Moat top 48%Tech bottom 49% All 7 signals ▾Fundingtop 29% Growthtop 45% Moattop 48% Techbottom 49% Talentbottom 49% Globalbottom 38% Marketbottom 33% Funding: Raised $56.7M across 2 rounds · 2 rounds over 6 yrs (0.3/yr) Growth: Web rank 10,000,000 → 50,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 37/100 | $57M | 17 mo ago | Series B | 24 | Miquel Vila-Perello CEO | WordPressMySQLPHP+22 | — | — |
| 2 | STAT Diagnostica Provider of a diagnostic platform for molecular diagnostics and immunoassays | $54M | 121 mo ago | Series C | — | Jordi Carrera Co-Founder & Managing Director | — | 113 patents Microfluidic cartridges for nucleic acid purification and biochemical assay automation | — |
| 3 | ADmit Therapeutics Provider of diagnostic services for early detection of Alzheimer's disease | $13M | 37 mo ago | Series A | 10 | Jordi Gascon Co-Founder | — | 18 patents Molecular diagnostic biomarkers for Lewy body and Alzheimer’s neurodegenerative diseases | — |
| 4 | Aelix Therapeutics Developer of therapies for treating HIV | $13M | 82 mo ago | Series A | 10 | Christian Brander Co-Founder | — | 25 patents TLR7‑agonist adjuvanted multiepitope HIV therapeutic vaccine formulations | — |
| 5 | Sequentia biotech Bioinformatics technologies and sevices | $11M | 25 mo ago | Series A | 23 | — | WordPressPleskMySQL+24 | — | — |
| 6 | AB-Biotics Developer of probiotic drugs for dental disorders | $7M | 102 mo ago | Acquired | 34 | Miquel Bonachera Co-Founder & CEO | WordPressPleskMySQL+24 | 145 patents Therapeutic probiotic strains and microbiome-based formulations for health and oral care | — |
| 7 | Integra Therapeutics Developer of next generation of gene editing tools to cure diseases | $7M | 14 mo ago | Seed | 9 | Marc Guell Co-Founder | WordPressMySQLPHP+18 | 10 patents Transposase-based gene delivery tools enhancing transgene expression and nuclear localization | — |
| 8 | Made of Genes Genomics platform for acquiring, storing, and sharing personal genomic information | $3M | 32 mo ago | Seed | 20 | — | WordPressMySQLPHP+25 | — | — |
| 9 | Flomics Provider of liquid biopsy-based diagnostics services | $2M | 32 mo ago | Seed | 19 | Joao Curado CEO | WordPressPleskMySQL+19 | — | — |
| 10 | Transbiomed Provider of genomics and proteomics based molecular diagnostics solutions | $2M | 188 mo ago | Deadpooled | — | Andreas Doll Co-Founder | — | — | — |
| 11 | Agrasys Online retailer of tools and equipment for garden and field | $579K | 141 mo ago | Seed | 8 | Cristobal Martinez Co-Founder | — | — | — |
| 12 | Pangaea Biotech Provider of drug development and molecular diagnostics services on cancer treatment | $298K | 106 mo ago | Public | 55 | — | WordPressMySQLPHP+22 | 104 patents Molecular diagnostics, nucleic acid isolation, luminescent biomarker assays, and oncology therapeutics | — |
| 13 | Qgenomics Provider of genomic research and diagnostics services for research purposes | $297K | 64 mo ago | Funding Raised | — | Lluis Armengol CEO and Scientific Director | WordPressAwesompleteMySQL+18 | — | — |
| 14 | Paperdrop Diagnostics Provider of rapid diagnostics tests for ageing issue based on lateral flow immunoassays | $210K | 72 mo ago | Funding Raised | — | Angel Alonso Co-Founder & CFO | — | 4 patents Patents concentrated in chemistry & materials | — |
| 15 | Moirai Biodesign Developer of RNA-based therapeutics and diagnostics for cancer | $115K | 88 mo ago | Seed | 6 | Ivan Dotu Co-founder and CTO | — | 11 patents Amplified RNA aptamer-based nucleic acid detection for disease diagnostics. | — |
Top 12 Genomics companies in Barcelona
#1
Series B · Barcelona, Catalonia · founded 2020 · 24 employees$56.7Mraised▾
Provider of a proprietary platform for gene therapy. The company offers proprietary intein platform technology for treating patients suffering from rare genetic diseases. The company's lead program is in Stargardt disease, the most common inherited retinal disorder caused by mutations in a single gene ABCA4.
- Jun 2025Series B$135M
- Feb 2022Series A$56.7M
- Sep 2020Seed—
#2
Seed · Barcelona, Catalonia · founded 2021 · 9 employees$6.8Mraised▾
Developer of next generation of gene editing tools to cure diseases. The company has combined the CRISPR systems with the gene transfer efficiency of viral integrases and transposases. It helps in introducing DNA into the genome with sequence-specific DNA binding proteins for developing gene therapies.
- Sep 2025Seed$12.5M
- Jan 2023Grant (prize money)$540.6K
- Mar 2022Seed$1.7M
- Dec 2021Seed$5.1M
#3
Series A · Barcelona, Catalonia · founded 2013 · 23 employees$11.2Mraised▾
Sequentia Biotech offers services and technologies in the field of bioinformatics. Work is organised into four specialised divisions: Sequentia Green, Sequentia Health, Sequentia Research, and Sequentia Training. The offerings include bioinformatics services, NGS services along with software for data analysis. It also has custom databses such as database for Plant resistance gene database PRGdb, Variation DB etc.
- Sep 2024Series A$11.2M
- Sep 2022Grant (prize money)$2.1M
- 2021Grant (prize money)$61.3K
- Apr 2021Grant (prize money)$86.6K
#4
Series A · Barcelona, Catalonia · founded 2017 · 10 employees$12.9Mraised▾
Provider of diagnostic services for early detection of Alzheimer's disease. The company is developing diagnostic tests by using next-generation sequencing analysis for the detection of biomarkers β-amyloid nor tau. The test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA.
- Oct 2023Series A$5.7M
- Jan 2021Grant (prize money)$3M
- Aug 2020Series A$5M
- Mar 2019Seed$2.3M
#5
Seed · Barcelona, Catalonia · founded 2015 · 20 employees$2.9Mraised▾
Genomics platform for acquiring, storing, and sharing personal genomic information. Genomcore provides end-customers a secure and compliant genomics platform for acquiring, storing, and sharing personal genomic information for its use in clinical and non-clinical applications. The company provides DNA sequencing services and computing services for genomic analysis. Users can obtain, analyze and manage their complete genomic sequence from the company's cloud platform.
- Feb 2024Seed—
- Jul 2020Seed$2.7M
- Jun 2015Seed$100K
- Feb 2015Seed$102K
#6
Seed · Barcelona, Catalonia · founded 2018 · 19 employees$2.3Mraised▾
Provider of liquid biopsy-based diagnostics services. The company offers a tailored sequencing workflow for RNA-based diagnostics using RNA liquid biopsy tests. It uses the Blood sample to obtain sequencing data to create liquid biopsies to enable the diagnosis of the patients.
- Mar 2024Seed$1.2M
- Mar 2022Seed$1.1M
#7
Series C · Barcelona, Catalonia · founded 2010$53.7Mraised▾
Provider of a diagnostic platform for molecular diagnostics and immunoassays. The proprietary DiagCore comprises an Analyzer that runs on consumable DiagCore cartridges. The STAT-Molecular cartridge automates sample homogenization, cell disruption, nucleic acid purification and delivers up to 50-plex target detection employing qPCR. This test cartridge is designed to automate molecular assays in the fields of infectious diseases, oncology, coagulation, prenatal, inherited diseases, or companion diagnostics. It offers test cartridges designed to automate immunoassays for critical care markers such as Procalcitonin (Sepsis), Troponin (AMI), Ngal (AKI), C-reactive protein (Inflammation), hCG (pregnancy), among others.
- Oct 2016Series C—
- Apr 2016Series C$28.5M
- May 2013Series B$22.3M
- 2011Series A$2.9M
#8
Series A · Barcelona, Catalonia · founded 2015 · 10 employees$12.6Mraised▾
Aelix Therapeutics develops therapies for HIV. It is a spinout from Barcelona's HIVACAT Research Center. The company plans to use polynucleotide sequences from T-cells derived from a cohort of HIV patients with naturally low viral loads. These sequence(s) will then be converted into DNA and delivered as a vaccine using a modified Ankara virus (MVA) as a vector. The vaccine has completed a Phase 1 trial.
- Jan 2020Grant (prize money)$600.2K
- Jul 2017Grant (prize money)$57.3K
- Jan 2016Series A$12.6M
#9
Acquired · Barcelona, Catalonia · founded 2004 · 34 employees$7.4Mraised▾
Developer of probiotic drugs for dental disorders. It also offers nutraceuticals for the pharmaceutical and food sectors. The company has a portfolio of 21 probiotic products in various categories including cardiometabolic, oral care, pediatrics, gastrointestinal health, gynecology, urology, dermatology, and immunology. It develops drugs for CNS disorders. It also offers services in genetic analyses for conducting pharmacogenetic studies.
- May 2018Post IPO—
- Mar 2018Grant (prize money)$61.6K
- Oct 2017Grant (prize money)$59K
- Jan 2017Grant (prize money)$52.8K
#10
Deadpooled · Barcelona, Catalonia · founded 2007$1.6Mraised▾
Transbiomed is a provider of genomics and proteomics-based molecular diagnostics solutions. It has developed products through biomarker discovery programs. Flagship product is for the diagnosis of prostrate cancer using a proprietary panel of biomarkers that is administered in conjunction with a standard PSA test.
- Feb 2011Series A$1.6M
#11
Funding Raised · Barcelona, Catalonia · founded 2020 · 16 employees$81.9Kraised▾
Provider of transcriptomic tests that focused on reversing aging. It offers a blood test that analyzes the RNA levels to examine the expression of all genes in the genome associated with different metabolic pathways.
- Jul 2023Grant (prize money)$81.9K
#12
Funding Raised · Barcelona, Catalonia · founded 2008$297.4Kraised▾
Provider of genomics medicine and consulting services based in Barcelona, Spain. The company offers genomics research, customized gene studies, genomic medicine and genetic counseling services to clients.
- Jul 2021Grant (prize money)$297.4K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Genomics coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics in Barcelona is moving
A read on the academic research around Bioinformatics in Barcelona — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 193 papers.
- Universitat de Barcelona51
- Universitat Autònoma de Barcelona45
- Barcelona Supercomputing Center28
- Hospital Clínic de Barcelona24
- Barcelona Institute for Global Health12
- Genome9
- Transcriptome6
- Gene5
- Identification (biology)5
- Transcription factor5
- MEDLINE1→3
- Disease4
- MEDLINE3
- Pharmacogenomics3
- Antimicrobial peptides2
- Biomarker2
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.